|
⚲
|
| Keyboard |
| Gorman John
✚
|
|
|---|---|
| CIK # | 0001382969 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001382969] | |
| 4 | [0001382969] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gorman John | |
| Northsight Capital Inc | |
| Health Enhancement Products Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Health Enhancement Products Inc HEP
Common Stock
|
2013-06-18 | Buy | 61,000 | $0.39 | 23,790 |
|
Health Enhancement Products Inc HEP
Common Stock
|
2013-06-15 | Tax withheld | 195,313 | $0.38 | 74,219 |
|
Health Enhancement Products Inc HEP
Common Stock
|
2013-06-15 | Option exercise | 500,000 | $0.15 | 75,000 |
|
Health Enhancement Products Inc HEP
Common Stock Purchase Warrant · derivative
|
2013-06-15 | Option exercise | 500,000 | $0.00 | |
|
Health Enhancement Products Inc HEP
Common Stock Purchase Warrant · derivative
|
2012-11-01 | Grant | 50,000 | $0.00 | |
|
Health Enhancement Products Inc HEPI.OB
Common Stock Purchase Warrant · derivative
|
2011-11-23 | Grant | 300,000 |